Biotech Growth Trust plc (The) (BIOG) Ordinary 25p
28.00p
(1.68%)
- Add to watchlist
- Create an alert
- This stock can be held in a
28.00p
(1.68%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
28.00p
(1.68%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
1,700.00p
1,709.86p
1,706.00p
1,670.24
1,670.00p
1,680.31p
680.00p
-1.21%
20.00p (1.21%) Previous:
20.00p
134,598
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
| 1 week 1W | 3.28% | 1 year 1Y | 76.16% |
|---|---|---|---|
| 1 month 1M | 5.16% | 2 years 2Y | 135.88% |
| 3 months 3M | 16.62% | 3 years 3Y | 116.32% |
| 6 months 6M | 23.25% | 5 years 5Y | 168.06% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
| Benchmark: | NASDAQ Biotechnology TR GBP |
|---|---|
| Annual management charge: | 0.65% of Net Assets |
| Performance fee: | Yes |
| Ongoing charge: | 1.10% |
| Dividend yield: | n/a |
| Dividend frequency: | Annually |
| Total assets: | £690m |
| Gross gearing: | 100% |
| Market capitalisation:Market cap.: | £675m |
| Shares in issue: | 40.78 million |
| Legal structure | Closed Ended Investment Company |
| Domicile: | United Kingdom |
| ISIN | GB0000385517 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.
Ready to take your first step?
To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.
Important Documents
Objective
NET ASSET VALUE (NAV)
| Estimated NAV: | 1,670.24 |
|---|---|
| Latest actual NAV: | 1,666.83 |
| Latest actual NAV date: | 15 January 2021 |
| Premium/Discount: | -1.21% |
| 12m average Premium/Discount: | -3.48% |
| NAV frequency: | Daily |
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
| Security | Weight |
|---|---|
| Horizon Therapeutics plc Ordinary Shares | 4.85% |
| Neurocrine Biosciences Inc | 4.33% |
| Biogen Inc | 4.17% |
| Vertex Pharmaceuticals Inc | 3.71% |
| Burning Rock Biotech Ltd ADR | 3.62% |
| Turning Point Therapeutics Inc | 3.43% |
| Alexion Pharmaceuticals Inc | 3.24% |
| Amgen Inc | 3.08% |
| Acceleron Pharma Inc | 2.99% |
| Forte Biosciences Inc Equity Wrt 20/Aug/2021 Usd 1 | 2.91% |
| Sector | Weight |
|---|---|
| Healthcare | 94.10% |
| Country | Weight |
|---|---|
| United States | 70.40% |
| China | 9.74% |
| Canada | 7.76% |
| Switzerland | 2.51% |
| United Kingdom | 2.28% |
| Cayman Islands | 0.80% |
| Ireland | 0.68% |
| Denmark | 0.40% |
| Germany | 0.31% |
| Sweden | 0.02% |
Key Dates
| Launch date: | 23 June 1997 |
|---|---|
| Financial year end: | March |
| Next AGM: | July 2021 |
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.